SMAD4 and neoplasm: Alazzouzi et al (2005) studied 86 Dukes' C colorectal cancer patients and showed that patients with Dukes' C tumours expressing high Smad4 protein levels had significantly better overall (P<0.025) and disease-free (P<0.013) survival than patients with low levels by immunohistochemical staining.